An Observational, Prospective, Multicentre Study to Assess the Sensitivity to Change of the SAMANTA Questionnaire in Women With Heavy Menstrual Bleeding (HMB)
Latest Information Update: 25 Jun 2020
At a glance
- Drugs Estradiol valerate/dienogest (Primary) ; Levonorgestrel (Primary) ; Medroxyprogesterone (Primary) ; Hormone replacements
- Indications Menorrhagia
- Focus Therapeutic Use
- Acronyms SAMIRA
- Sponsors Bayer
- 22 Jun 2020 Planned primary completion date changed from 16 Feb 2021 to 21 Feb 2021.
- 21 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 21 Jan 2020 Planned End Date changed from 28 Feb 2021 to 28 Apr 2021.